Shire PLC Company Profile (LON:SHP)

About Shire PLC

Shire PLC logoShire plc is a biotech company. The Company, along with its subsidiaries, is engaged in developing and marketing medicines for patients with rare diseases and other select conditions. The Company operates in the segment of research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. The Company focuses its development resources on projects in various therapeutic areas (TAs), including rare diseases, neuroscience, ophthalmics, hematology and gastrointestinal (GI), and focuses its early development projects primarily on rare diseases. Its products include VYVANSE/VENVANSE/ELVANSE/TYVENSE/ELVANSE VUXEN/ADUVANZ, ADDERALL XR, INTUNIV, LIALDA (mesalamine)/MEZAVANT(mesalazine), PENTASA (mesalamine), REPLAGAL (agalsidase alfa), ELAPRASE (idursulfase), VPRIV (velaglucerase alfa), FIRAZYR (icatibant), CINRYZE C1 esterase inhibitor (human), GATTEX/REVESTIVE, NATPARA/NATPAR, FOSRENOL (lanthanum carbonate) and KALBITOR.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: SHP
  • CUSIP:
Key Metrics:
  • Previous Close: $66.02
  • 50 Day Moving Average: $4959.22
  • 200 Day Moving Average: $4295.51
  • Trailing P/E Ratio: 30.56
  • P/E Growth: 1.05
  • Market Cap: $33.47B
  • Outstanding Shares: 682,799,000
Additional Links:

Analyst Ratings

Consensus Ratings for Shire PLC (LON:SHP) (?)
Ratings Breakdown: 1 Sell Rating, 1 Hold Rating, 17 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 2.90)
Consensus Price Target: GBX 5,841.33

Analysts' Ratings History for Shire PLC (LON:SHP)
Show:
DateFirmActionRatingPrice TargetDetails
8/23/2016JPMorgan Chase & Co.Reiterated RatingOverweightGBX 6,300View Rating Details
8/18/2016BNP ParibasReiterated RatingOutperformGBX 5,900View Rating Details
8/12/2016Shore CapitalReiterated RatingBuyView Rating Details
8/3/2016Jefferies GroupBoost Price TargetBuyGBX 6,050 -> GBX 6,600View Rating Details
8/3/2016Credit Suisse Group AGBoost Price TargetOutperformGBX 5,000 -> GBX 5,200View Rating Details
8/3/2016Goldman Sachs Group Inc.Reiterated RatingConviction-BuyGBX 6,300View Rating Details
8/3/2016Citigroup Inc.Reiterated RatingBuyView Rating Details
8/3/2016Deutsche Bank AGReiterated RatingBuyGBX 6,000View Rating Details
8/3/2016Royal Bank Of CanadaReiterated RatingOutperformView Rating Details
7/29/2016Liberum CapitalReiterated RatingBuyGBX 5,500View Rating Details
7/6/2016Berenberg BankReiterated RatingBuyGBX 5,800View Rating Details
7/1/2016HSBCReiterated RatingBuyGBX 5,400View Rating Details
6/3/2016Morgan StanleyReiterated RatingOverweightGBX 5,600View Rating Details
3/15/2016Sanford C. BernsteinReiterated RatingOutperformGBX 5,000View Rating Details
3/10/2016AlphaValueReiterated RatingBuyGBX 6,420View Rating Details
1/12/2016S&P Equity ResearchReiterated RatingBuyView Rating Details
1/5/2016Barclays PLCReiterated RatingOverweightGBX 5,700View Rating Details
12/3/2015InvestecDowngradeSellView Rating Details
11/3/2015Kepler Capital MarketsLower Price TargetBuyGBX 6,000 -> GBX 5,900View Rating Details
10/19/2015Bank of America Corp.Reiterated RatingNeutralGBX 6,000View Rating Details
5/18/2015XYZ ResearchReiterated RatingOutperformGBX 6,600View Rating Details
4/30/2015Charles StanleyReiterated RatingaccumulateView Rating Details
(Data available from 8/25/2014 forward)

Earnings

Earnings History for Shire PLC (LON:SHP)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Shire PLC (LON:SHP)
Current Year EPS Consensus Estimate: $4.31 EPS

Dividends

Dividend History for Shire PLC (LON:SHP)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/2/2016GBX 3.510.07%9/8/20169/8/201610/7/2016
2/11/2016GBX 15.320.44%3/10/20163/10/20164/12/2016
7/23/2015GBX 2.690.05%9/3/20159/3/201510/2/2015
7/18/2014GBX 2.240.04%9/3/20149/3/201410/3/2014
2/13/2014GBX 10.210.31%3/5/20143/5/20144/8/2014
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Shire PLC (LON:SHP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/30/2016Bohuon,OlivierInsiderBuy134GBX 4,463£5,980.42
3/31/2016Bohuon,OlivierInsiderBuy133GBX 3,908£5,197.64
2/15/2016Bohuon,OlivierInsiderBuy1,000GBX 3,552£35,520
2/12/2016Burns,WilliamInsiderBuy1,250GBX 3,563£44,537.50
12/18/2015Burns,WilliamInsiderBuy156GBX 4,457£6,952.92
9/30/2015Blakemore ,DominicInsiderBuy129GBX 4,498£5,802.42
6/30/2015Kappler,David JInsiderBuy126GBX 51.05GBX 6,432.30
3/31/2015Susan KilsbyInsiderBuy375GBX 5,327£19,976.25
12/19/2014Steven GillisInsiderBuy228GBX 4,654£10,611.12
10/30/2014Steven GillisInsiderBuy381GBX 4,098£15,613.38
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Shire PLC (LON:SHP)
DateHeadline
investors.com logoMylan boss take the fight to Hillary (LON:SHP)
www.proactiveinvestors.com - August 25 at 12:30 PM
proactiveinvestors.co.uk logoShire leads the fallers as £3.7bn is wiped from drugs sector after Clinton blast (LON:SHP)
www.proactiveinvestors.co.uk - August 25 at 12:30 PM
capitalcube.com logoETF’s with exposure to Shire Plc : August 24, 2016 (LON:SHP)
www.capitalcube.com - August 24 at 7:06 PM
capitalcube.com logoShire Plc :SHP-GB: Earnings Analysis: Q2, 2016 By the Numbers : August 23, 2016 (LON:SHP)
www.capitalcube.com - August 23 at 11:55 AM
4-traders.com logoShire : Elections for the interim dividend (LON:SHP)
www.4-traders.com - August 19 at 7:15 PM
News IconSHIRE PLC - Elections for the interim dividend (LON:SHP)
uk.advfn.com - August 19 at 7:15 PM
publicnow.com logoElections for the interim dividend (LON:SHP)
www.publicnow.com - August 19 at 7:15 PM
publicnow.com logoElections for the interim dividend in ... (LON:SHP)
www.publicnow.com - August 19 at 7:15 PM
News IconSHIRE PLC - Half-year Report (LON:SHP)
uk.advfn.com - August 8 at 12:11 PM
ftsenews.co.uk logoShire PLC (LON:SHP) Issued With 'Buy' Rating At Jefferies ... - FTSE News (LON:SHP)
www.ftsenews.co.uk - August 5 at 10:27 AM
finance.yahoo.com logoEdited Transcript of SHP.L earnings conference call or presentation 2-Aug-16 1:00pm GMT (LON:SHP)
finance.yahoo.com - August 3 at 10:42 AM
finance.yahoo.com logoShire Delivers Strong Q2 2016 Revenue Growth; Upgrades Outlook (LON:SHP)
finance.yahoo.com - August 2 at 12:22 PM
nasdaq.com logoShire Plc Q2 Profit Tops Estimates; Updates 2016 Guidance (LON:SHP)
www.nasdaq.com - August 2 at 12:22 PM
breakingfinancenews.com logoUBS announced (LON:SHP) Shire Plc, increasing its stock price target to 5,200GBX earlier today (LON:SHP)
breakingfinancenews.com - August 2 at 12:22 PM
investors.com logoShire boosts savings target from Baxalta (LON:SHP)
www.proactiveinvestors.com - August 2 at 12:22 PM
nasdaq.com logoShire : FDA Approves BAXJECT III Reconstitution System For ADYNOVATE (LON:SHP)
www.nasdaq.com - August 1 at 12:02 PM
News IconShire Announces FDA Approval of adynovate with BAXJECT III Reconstitution System (LON:SHP)
www.medindia.net - August 1 at 12:02 PM
stockhouse.com logoSHIRE PLC - Total Voting Rights (LON:SHP)
www.stockhouse.com - August 1 at 12:02 PM
News IconLatest news on Shire (LON:SHP)
www.stockopedia.com - July 29 at 7:34 PM
breakingfinancenews.com logoShire PLC (LON:SHP) target price maintained at 5,500GBX as issued in a report today by Liberum Capital (LON:SHP)
breakingfinancenews.com - July 29 at 7:34 PM
ftsenews.co.uk logoExane BNP Paribas reiterated Shire Plc (LON:SHP) as 'Outperform' With 5700 PT - FTSE News (LON:SHP)
www.ftsenews.co.uk - July 28 at 10:40 AM
marketrealist.com logoHow Will Shire’s ADHD Franchise Perform in 2Q16? (LON:SHP)
marketrealist.com - July 27 at 9:12 AM
marketrealist.com logoHow Much Revenue Growth Will Shire Record in 2Q16? (LON:SHP)
marketrealist.com - July 26 at 5:17 PM
News IconONIVYDE® Receives Positive CHMP Opinion for Treatment of Patients with Metastatic Adenocarcinoma of the Pancreas Who Have Pr... (LON:SHP)
uk.advfn.com - July 25 at 7:33 PM
nasdaq.com logoMerrimack: ONIVYDE Regimen Gets Positive CHMP Opinion In EU -Quick Facts (LON:SHP)
www.nasdaq.com - July 25 at 11:50 AM
prnewswire.com logoONIVYDE® Receives Positive CHMP Opinion for Treatment of Patients with ... (LON:SHP)
www.prnewswire.com - July 25 at 11:50 AM
fiscalstandard.com logoShire Plc (LON:SHP) Analyst Target Changes - Fiscal Standard (LON:SHP)
www.fiscalstandard.com - July 21 at 10:14 AM
proactiveinvestors.co.uk logoFTSE 100 Index pares gains as pound rises on UK job news (LON:SHP)
www.proactiveinvestors.co.uk - July 20 at 10:18 AM
ftsenews.co.uk logoShire Plc (LON:SHP) New Price Targets - FTSE News (LON:SHP)
www.ftsenews.co.uk - July 19 at 9:36 AM
finance.yahoo.com logoShire Reinforces Commitment in Hematology with Robust Data Presented at International Congress of the World Federation of Hemophilia (LON:SHP)
finance.yahoo.com - July 19 at 7:00 AM
News IconAre Analysts Bullish Shire PLC (LON:SHP) After Last Week? - Consumer Eagle (LON:SHP)
www.consumereagle.com - July 16 at 6:47 PM
News IconShire PLC (LON:SHP) Stock Rating Reiterated at Liberum Capital; The GBX 5500.00 Target Indicates 12.80% Potential - Consumer Eagle (LON:SHP)
www.consumereagle.com - July 15 at 12:38 PM
breakingfinancenews.com logoShire PLC (LON:SHP) price target held steady at 5500GBX as issued in a report today by Liberum Capital - Breaking Finance News (LON:SHP)
breakingfinancenews.com - July 15 at 12:38 PM
breakingfinancenews.com logoShire PLC (LON:SHP) price target held steady at 5,500GBX as issued in a report today by Liberum Capital (LON:SHP)
breakingfinancenews.com - July 14 at 7:40 PM
breakingfinancenews.com logoA report released today by Deutsche Bank about Shire PLC(LON:SHP) maintains the target price at 6,000GBX (LON:SHP)
breakingfinancenews.com - July 14 at 11:02 AM
breakingfinancenews.com logoA statement released today by JP Morgan Cazenove about Shire PLC(LON:SHP) holds the target price at 5,600GBX (LON:SHP)
breakingfinancenews.com - July 13 at 7:48 PM
News IconMultimedia assets now available: FDA Approves Shire's Xiidra™ (lifitegrast ophthalmic solution) 5% - … (LON:SHP)
www.yahoo.com - July 13 at 10:17 AM
breakingfinancenews.com logoLiberum Capital recorded (LON:SHP) Shire PLC, keeping its price target at 5,500GBX earlier today (LON:SHP)
breakingfinancenews.com - July 13 at 10:17 AM
finance.yahoo.com logoFDA approves Shire's keenly-watched eye drug (LON:SHP)
finance.yahoo.com - July 12 at 7:38 PM
News IconShire’s Xiidra receives FDA approval for treating dry eye disease in adult patients (LON:SHP)
www.news-medical.net - July 12 at 11:47 AM
News IconShire Surges After FDA Approves Xiidra Drops for Dry-Eye Disease (LON:SHP)
potiner.com - July 12 at 11:47 AM
News IconFDA approves Shire’s keenly-watched eye drug (LON:SHP)
www.euronews.com - July 12 at 11:47 AM
proactiveinvestors.co.uk logoGreen light for Shire dry eye drug adds £1.3bn to co's value (LON:SHP)
www.proactiveinvestors.co.uk - July 12 at 11:47 AM
breakingfinancenews.com logoGoldman Sachs issued a report on (LON:SHP) Shire Plc, hiking its target price to 6,300GBX today (LON:SHP)
breakingfinancenews.com - July 12 at 11:47 AM
sg.finance.yahoo.com logoDow, S&P 500 hit record highs on greater risk tolerance (LON:SHP)
sg.finance.yahoo.com - July 12 at 11:06 AM
uk.finance.yahoo.com logoGLOBAL MARKETS-Dow, S&P 500 hit record highs on greater risk tolerance (LON:SHP)
uk.finance.yahoo.com - July 12 at 11:05 AM
publicnow.com logoShire Receives Extension of Market ... (LON:SHP)
www.publicnow.com - July 7 at 2:21 AM
finance.yahoo.com logoShire Receives Extension of Market Authorization in Europe for Revestive▼ (Teduglutide) for the Treatment of Paediatric Patients with Short Bowel Syndrome (SBS) (LON:SHP)
finance.yahoo.com - July 7 at 2:00 AM
breakingfinancenews.com logoDeutsche Bank recorded (LON:SHP) Shire PLC, boosting its price target to GBX6,000 today (LON:SHP)
breakingfinancenews.com - July 5 at 11:49 AM
breakingfinancenews.com logoShire Plc (LON:SHP) price target bumped up to GBX5,000, reported today by Credit Suisse (LON:SHP)
breakingfinancenews.com - July 4 at 11:56 AM

Social


Last Updated on 8/25/2016 by MarketBeat.com Staff